DEEPAKNTRBSEDEEPAK NITRITE LTD· Chemicals & PetrochemicalsHighNegative
Announced Fri, 21 Aug, 2026 · 18:25 IST

SBU Head Life Sciences Puneet Sharma resigns from Deepak Nitrite

DEEPAKNTR · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-0.0%Reaction day
₹1740.00
prior close
₹1749.90
announcement price
After-mkt
timing
Nifty Smallcap 250market-0.2%+0.2% vs market
Specialty Chemicals peers, median of 101sector-0.2%+0.2% vs sector

On the reaction day the stock moved 0.2 pts more than Nifty Smallcap 250 and 0.2 pts more than its Specialty Chemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.3
10m
+0.6
15m
+1.0
30m
+1.1
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-0.0-0.2+0.2-0.2+0.2
Next day
+0.8-0.4+1.2+0.0+0.8
2d
+2.4+0.2+2.2+0.3+2.1
3d
+0.8+0.1+0.7+0.1+0.7
4d
+1.4+0.4+0.9+0.1+1.3
5d
+0.3-0.2+0.5-0.0+0.3
1w
-0.2-0.9+0.6+0.1-0.3
15d
-10.1-2.8-7.2-1.0-9.0
1m
-7.9-1.4-6.5+0.8-8.8
2m
-17.2-10.0-7.2-9.0-8.2
3m
—————
UpDownMarket · Nifty Smallcap 250Sector · Specialty Chemicals peers, median of 101Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mr. Puneet Sharma, SBU Head Life Sciences at Deepak Nitrite, has resigned effective close of business on 21st August 2026. In his resignation letter dated 23 May 2026, he said he is taking up an opportunity outside the company for the next chapter of his career. His tenure covered the agrochemical and pharma intermediates, personal care, and emerging platforms divisions. Last working day was 21st August 2026 after a contractual three-month notice. He has committed to a smooth handover.

Likely market impact

Loss of a senior leader heading the Life Sciences division. Watch for succession announcement and any near-term business development continuity updates.